Article citationsMore>>

Schuler, M., Awada, A., Harter, P., Canon, J.L., Possinger, K., Schmidt, M., et al. (2012) A Phase II Trial to Assess Efficacy and Safety to Afatinib in Extensively Pretreated Patients with HER2-Negative Metastatic Breast Cancer. B Breast Cancer Research and Treatment, 134, 1149-1159.
https://doi.org/10.1007/s10549-012-2126-1

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
+1 323-425-8868
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top